Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT06192823
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Not accepted
Study Details
This study will evaluate the feasibility of adding objective measures (FDG-PET imaging, wearable biosensors) to a week-long washout protocol in early-stage Parkinson's disease patients. This study is also determining whether the washout can be conducted in the ambulatory setting.
Key Dates
- Start date
- Mar 22, 2022
- Status verified
- Apr 2026
- Primary completion
- Feb 18, 2025
- Completion
- Feb 18, 2025
Study Design
- Enrollment
- 20 participants (actual)
Primary Outcome Measure
Changes in the Parkinson's Disease Related Pattern (PDRP) Z-Score From ON Medications to One-week OFF Medications [ Time Frame: Day 1 and Day 8 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | - |
Find similar trials in Nashville, TN
By condition
By specialty
By research site
Related Studies
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian TremorRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailurePHASE1 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- [18F]F-DOPA Imaging in Patients With Autonomic FailurePHASE1 · Recruiting · Daniel Claassen · Nashville, Tennessee